StockWatch
·
Pharmaceuticals
Board Meeting7 Sept 2026, 08:30 pm

ANG Lifesciences Board Approves AGM, Cost Auditor, Director Re-appointments

AI Summary

ANG Lifesciences India Ltd's Board of Directors met on September 7, 2026, approving key corporate actions. The board appointed M/s Shreya Sahu & Associates as the Cost Auditor for FY 2026-27 and approved the Board's report for FY 2025-26. The 20th Annual General Meeting is scheduled for September 30, 2026, with a book closure period from September 24 to September 30, 2026. The board also approved the re-appointment of Mr. Rohit Mittal and Mrs. Chetna as an Independent Director for a second five-year term, subject to shareholder approval.

Key Highlights

  • Board approved appointment of Cost Auditor for FY 2026-27.
  • 20th Annual General Meeting scheduled for September 30, 2026.
  • Book closure period set from September 24 to September 30, 2026.
  • Re-appointment of Mr. Rohit Mittal approved.
  • Mrs. Chetna re-appointed as Independent Director for a second term.